Please login to the form below

Not currently logged in
Email:
Password:

Axovant

This page shows the latest Axovant news and features for those working in and with pharma, biotech and healthcare.

Oxford Biomedica gets £53m cash injection from Novo venture arm

Oxford Biomedica gets £53m cash injection from Novo venture arm

Among these is OXB-102 (AXO-Lenti-PD), a Parkinson’s disease candidate which was outlicensed to Axovant Gene Therapies, and from whom the firm recently received a milestone payment when

Latest news

More from news
Approximately 6 fully matching, plus 8 partially matching documents found.

Latest appointments

More from appointments
Approximately 1 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
dna Communications

Healthcare communications with unique thinking, insight and attitude...

Latest intelligence

Empowered patients: shaking the foundations of healthcare
Precision medicine represents a new paradigm in healthcare.This new approach to treating and preventing disease views the patient holistically, analysing their genes, environment and lifestyle, and using this information to...
A uniquely English genomic medicine service
The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....

Infographics